BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jang SM, Bahjri K, Tran H. Safety and Efficacy of Direct Oral Anticoagulants for Atrial Fibrillation in Patients with Renal Impairment. Pharmacy (Basel) 2020;8:E30. [PMID: 32143504 DOI: 10.3390/pharmacy8010030] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Su X, Yan B, Wang L, Lv J, Cheng H, Chen Y. Oral Anticoagulant Agents in Patients With Atrial Fibrillation and CKD: A Systematic Review and Pairwise Network Meta-analysis. Am J Kidney Dis 2021;78:678-689.e1. [PMID: 33872690 DOI: 10.1053/j.ajkd.2021.02.328] [Reference Citation Analysis]
2 Lamarche MC, Alrajhi E, Wells PS. Direct oral anticoagulant use in special populations. Curr Opin Pulm Med 2021;27:311-8. [PMID: 34115699 DOI: 10.1097/MCP.0000000000000787] [Reference Citation Analysis]
3 White EM, Coons JC. Direct Oral Anticoagulant Use in Special Populations: Elderly, Obesity, and Renal Failure. Curr Cardiol Rep 2021;23:27. [PMID: 33655373 DOI: 10.1007/s11886-021-01456-9] [Reference Citation Analysis]